Thursday, August 06, 2009

Pancreas cells can be stimulated to produce insulin

Source: Max Planck Institute
Date: August 6, 2009

Summary:

If the insulin-producing cells of our body based, it can develop diabetes - one of the most common metabolic disease of western industrialized nations. Through the body's own insulin-producing cells to replace, has long been a dream of diabetes researchers. Scientists at the Max Planck Institute for Biophysical Chemistry (Göttingen) this goal are now one step closer to. Turns the researchers in diabetic mice, a single gene in the pancreatic cells, it turned them into insulin-producing cells. Could this conversion in humans selectively regulate the future, this could open up new therapeutic pathways to diabetes successfully treated. The study is published in the journal Cell

Below is additional coverage of this development from various sources:

Juvenile Diabetes Research Foundation, August 6, 2009: "Researchers Show Non-Insulin-Producing Alpha Cells in the Pancreas Can Be Converted To Insulin-Producing Beta Cells":

"In findings that add to the prospects of regenerating insulin-producing cells in people with type 1 diabetes, researchers in Europe -- co-funded by the Juvenile Diabetes Research Foundation -- have shown that insulin-producing beta cells can be derived from non-insulin-producing cells in the pancreas."

Los Angeles Times, August 8, 2009: "Scientists alter pancreatic cells to treat Type 1 diabetes":

"... a team of European and American researchers showed that pancreatic cells in diabetic mice could be reprogrammed into beta cells by turning on just one gene, called Pax4. The scientists gave the mice a chemical called streptozotocin that killed off their beta cells while preserving other types of pancreatic cells. Then they activated the Pax4 gene, which does most of its work during fetal development."

What Makes Stem Cells Tick? Researchers Identify Phosphorylated Signaling Proteins in Human Embryonic Stem Cells

Source: Burnham Institute for Medical Research
Date: August 6, 2009

Summary:

LA JOLLA, Calif., -- Investigators at the Burnham Institute for Medical Research (Burnham) and The Scripps Research Institute (TSRI) have made the first comparative, large-scale phosphoproteomic analysis of human embryonic stem cells (hESCs) and their differentiated derivatives. The data may help stem cell researchers understand the mechanisms that determine whether stem cells divide or differentiate, what types of cells they become and how to control those complex mechanisms to facilitate development of new therapies. The study was published in the August 6 issue of the journal Cell Stem Cell.

Scientists Find Key to Strengthening Immune Response to Chronic Infection

Source: Wistar Institute
Date: August 6, 2009

A team of researchers from The Wistar Institute has identified a protein that could serve as a target for reprogramming immune system cells exhausted by exposure to chronic viral infection into more effective “soldiers” against certain viruses like HIV, hepatitis C, and hepatitis B, as well as some cancers, such as melanoma.

Effective response by key immune cells in the body, called T cells, is crucial for control of many widespread chronic viral infections such as HIV and hepatitis B and C. Virus-specific CD8 T cells, also known as “killer” T cells, often lose their ability to control viral replication and become less effective over time, a process known as T cell exhaustion. Understanding how optimal antiviral T cell responses are suppressed in these circumstances is crucial to developing strategies to prevent and treat such persisting infections.

In the August 6 on-line issue of Immunity, the research team led by Wistar assistant professor E. John Wherry, Ph.D., describes how the protein Blimp-1 (B-lymphocyte-induced maturation protein 1) represses the normal differentiation of CD8 T cells into memory T cells, which recognize disease-causing agents from previous infections and enable the body to mount faster, stronger immune responses. The team also reports that Blimp-1 causes exhausted CD8 T cells to express inhibitory receptors, which prevent recognition of specific antigens, further weakening immune response.

Scientists find common trigger in cancer and normal stem cell reproduction

Source: Stanford University Medical Center
Date: August 6, 2009

Summary:

STANFORD, Calif. — Researchers at Stanford University School of Medicine have discovered, for the first time, a common molecular pathway that is used by both normal stem cells and cancer stem cells when they reproduce themselves. In a paper to be published Aug. 7 in the journal Cell, Michael Clarke, MD, the Karel H. and Avice N. Beekhuis Professor in Cancer Biology, and his colleagues showed that breast cancer stem cells and normal breast stem cells turn down the creation of a specific group of cell signals when they are reproducing. Increasing the amount of one of these signals, called miR-200c, strongly suppressed the ability of both cancer stem cells and normal stem cells to divide and reproduce. The discovery of a common regulatory pathway in both kinds of stem cells supports the idea that cancer stem cells and normal stem cells share fundamental properties.

Wednesday, August 05, 2009

U of T researchers learn how blood cells 'talk'

Source: University of Toronto
Date: August 5, 2009

Summary:

Researchers at the University of Toronto have developed a new model that explains how cells communicate and specifically reveals how blood cells "talk" to each other. The result could help transform treatments for diseases such as leukemia.

The paper, published online by the journal Molecular Systems Biology, details how a team led by Canada Research Chair in Stem Cell Bioengineering Professor Peter Zandstra (Institute of Biomaterials and Biomedical Engineering, Department of Chemical Engineering and Applied Chemistry) revealed a new mathematical model that links functional cellular assays to specific model outputs, defines cell-level kinetic parameters such as cell cycle rates and self-renewal probabilities as functions of culture variables, and simulates feedback regulation using cell-cell interaction networks.

Stem cell hierarchy offers potential for isolating, growing cells

Source: University of Toronto
Date: August 4, 2009

Summary:

Researchers at the University of Toronto Institute of Biomaterials and Biomedical Engineering (IBBME) and Princess Margaret Hospital (PMH), led by U of T's Professor J.E. Davies, have made important progress in stem cell research that will allow for numerous applications of multi-faceted stem cells known as mesenchymal stem cells (MSCs). This research will advance the selection of specific cells to target specific diseases, ultimately enabling clinicians to "personalize" treatment for patients.

The important research published today in the Public Library of Science journal, PloS-ONE [http://www.plosone.org/home.action], is entitled Human Mesenchymal Stem Cells Self-Renew and Differentiate According to a Deterministic Hierarchy. The paper provides the experimental proof of the existence of a human MSC at the single cell level, a key step that has previously eluded the scientific community. The researchers have for the first time, defined a mesenchymal stem cell hierarchy that introduces the possibility of isolating and growing MSCs of different capacities for different clinical applications or drug discovery.This development builds on the team's previous finding that the richest source of MSCs in the body is found in umbilical cord tissue that is normally discarded at birth.

Tuesday, August 04, 2009

Gene signature for cancer stem cells may provide drug targets

Source: Baylor College of Medicine
Date: August 4, 2009

Summary:

A subset of tumor cells that remain after a woman with breast cancer undergoes treatment with either anti-cancer or anti-hormone therapy shows a "gene signature" that could be used to define targets for developing new drugs against the disease, said a consortium of researchers led by Baylor College of Medicine. The report appears in the current issue of the Proceedings of the National Academy of Sciences.

New stem cell research could make lab mice redundant

Source: University of Bath
Date: 04 August 2009

Summary:

Researchers from the University of Bath are embarking on a project to use stem cell technology that could reduce the number of animal experiments used to study conditions such as motor neurone disease. Dr Vasanta Subramanian, from the University’s Department of Biology & Biochemistry, will be developing a technique using human stem cells to study this debilitating neurological disease, greatly reducing the number of animals used in research.

Scientists find way to coax human stem cells into becoming T cells

Source: Sunnybrook Health Sciences Centre
Date: August 4, 2009

Summary:

Canadian researchers have developed a way to direct unspecified human stem cells into becoming progenitor (or early) T cells, which then go to the thymus and give rise to mature T cells, an essential ingredient in immune system reconstitution. This critical advance in regenerative medicine, published in the July 30 edition of Blood, makes possible new approaches to treating people with severe immune deficiencies, such as children born with little or no immune system, or people who have had chemotherapy. Scientists at Sunnybrook Research Institute created the human progenitor T cells from stem cells in the lab using a method that they patented. They then implanted them into immune-deficient mice, wherein the unspecified cells travelled to the thymus and produced mature T cells.

Monday, August 03, 2009

Researchers Demonstrate How Stem Cell Line Regenerates New Cardiac Cells

Source: University of Miami Miller School of Medicine
Date: August 3, 2009

Summary:

As the field of stem cell based therapies has progressed, there have been numerous questions about the exact way one of the most promising lines of adult stem cells works to repair damaged heart muscle. Although cells obtained from adult bone marrow are proving to be useful to treat heart disease, there has been a major controversy over whether they are true stem cells capable of forming new heart muscle.

Cardiologists at the University of Miami Miller School of Medicine have definitively shown that mesenchymal stem cells from bone marrow do in fact form new heart muscle and blood vessels, leading to major degrees of tissue repair in hearts damaged by a heart attack. Their findings have been published in the August 3 issue of the Proceedings of the National Academy of Sciences.

Finding the Right Connection after Spinal Cord Injury

Source: University of California - San Diego
Date: August 3, 2009

Summary:

In a major step in spinal cord injury research, scientists at the University of California, San Diego School of Medicine have demonstrated that regenerating axons can be guided to their correct targets and re-form connections after spinal cord injury. Their findings will be published in the advance online edition of the journal Nature Neuroscience on August 2.

The UC San Diego study looked at regenerating sensory axons in rat models of spinal cord injury. Sensory systems of the body send axons – long, slender projections of the neuron – into the spinal cord to convey information regarding touch, position, and pain. Many sensory axons are covered by an insulating myelin sheath which helps these impulses travel efficiently to the brain.

The UC San Diego scientists showed that regenerating axons can be guided to correct targets using a type of chemical hormone called a growth factor. The team utilized a type of chemical hormone, a nervous system growth factor called neurotrophin-3 (NT-3), to guide regenerating sensory axons to the appropriate target and support synapse formation. Regeneration required two other treatments at the same time: placing a cell bridge in the spinal cord injury site to support axon growth, and a “conditioning” stimulus to the injured neuron that turned on regeneration genes for new growth.

Stem cell ‘daughters’ lead to breast cancer

Source: Walter and Eliza Hall Institute
Date: 3 August 2009

Summary:

Walter and Eliza Hall Institute scientists have found that a population of breast cells called luminal progenitor cells are likely to be responsible for breast cancers that develop in women carrying mutations in the gene BRCA1.

BRCA1 gene mutations are found in 10-20 per cent of women with hereditary breast cancer. Women with BRCA1 mutations often develop 'basal-like' breast cancer, which is a particularly aggressive form of the disease.

A team led by Associate Professors Jane Visvader and Geoff Lindeman from the institute's Victorian Breast Cancer Research Consortium Laboratory have discovered that luminal progenitor cells – the 'daughters' of breast stem cells – are the likely source of basal-like breast tumours. Their finding, published in today's issue of the international journal Nature Medicine, represents a major shift in the way scientists think breast cancer develops.

Scientists discover bladder cancer stem cell

Source: Stanford University Medical Center
Date: August 3, 2009

Summary:

STANFORD, Calif. — Researchers at Stanford's School of Medicine have identified the first human bladder cancer stem cell and revealed how it works to escape the body's natural defenses. The study will be published in the Proceedings of the National Academy of Sciences on Aug. 3.

Thursday, July 30, 2009

Scientists program blood stem cells to become vision cells

Source: University of Florida
Date: July 30, 2009

Summary:

GAINESVILLE, Fla. — University of Florida researchers were able to program bone marrow stem cells to repair damaged retinas in mice, suggesting a potential treatment for one of the most common causes of vision loss in older people. The success in repairing a damaged layer of retinal cells in mice implies that blood stem cells taken from bone marrow can be programmed to restore a variety of cells and tissues, including ones involved in cardiovascular disorders such as atherosclerosis and coronary artery disease.

In a paper slated to appear in the September issue of the journal Molecular Therapy, scientists describe how they used a virus carrying a gene that gently pushed cultured adult stem cells from mice toward a fate as retinal cells. Only after the stem cells were reintroduced into the mice did they completely transform into the desired type of vision cells, apparently taking environmental cues from the damaged retinas.

Wednesday, July 29, 2009

Reprogramming human cells without inserting genes

Source: Worcester Polytechnic Institute
Date: July 29, 2009

Summary:

A research team comprised of faculty at Worcester Polytechnic Institute's (WPI) Life Sciences and Bioengineering Center (LSBC) and investigators at CellThera, a private company also located at the LSBC, has discovered a novel way to turn on stem cell genes in human fibroblasts (skin cells) without the risks associated with inserting extra genes or using viruses. This discovery opens a new avenue for reprogramming cells that could eventually lead to treatments for a range of human diseases and traumatic injuries by coaxing a patient's own cells to repair and regenerate the damaged tissues.

The research team reported its findings in the paper "Induction of Stem Cell Gene Expression in Adult Human Fibroblasts without Transgenes," published online July 21, 2009 (in advance of September print publication) as a "fast track" paper from the journal Cloning and Stem Cells. (Cloning, Stem Cells. 2009 Jul 21.) "We show that by manipulating culture conditions alone, we can achieve changes in fibroblasts that would be beneficial in development of patient-specific cell therapy approaches," the authors wrote in the paper.

Tuesday, July 28, 2009

Male Germ Cells Can Be Directly Converted Into Other Cell Types

Source: University of Illinois at Urbana-Champaign
Date: July 28, 2009

Summary:

CHAMPAIGN, lll. – Researchers at the University of Illinois at Urbana-Champaign have found a way to directly convert spermatogonial stem cells, the precursors of sperm cells, into tissues of the prostate, skin and uterus. Their approach, described this month in the journal Stem Cells, may prove to be an effective alternative to the medical use of embryonic stem cells. The new method, co-developed by postdoctoral researcher Liz Simon takes advantage of the unusual interaction of two tissue types: the epithelium and the mesenchyme.

The hunt for alternatives to embryonic stem cells has led to some promising yet problematic approaches, some of which involve spermatagonial stem cells (SSCs). Researchers recently observed, for example, that SSCs grown in the laboratory will eventually give rise to a few cells that look and act like embryonic stem cells. This process can take months, however, and only a small percentage of the SSCs are converted into “embryonic stem-like” cells.

Monday, July 27, 2009

How the pathology of Parkinson's disease spreads

Source: University of California - San Diego
Date: July 27, 2009

Summary:

Accumulation of the synaptic protein α-synuclein, resulting in the formation of aggregates called Lewy bodies in the brain, is a hallmark of Parkinson’s and other related neurodegenerative diseases. This pathology appears to spread throughout the brain as the disease progresses. Now, researchers at the University of California, San Diego School of Medicine and Konkuk University in Seoul, South Korea, have described how this mechanism works. Their findings – the first to show neuron-to-neuron transmission of α-synuclein – will appear in the Proceedings of the National Academy of Sciences (PNAS) on July 29. This insight will impact research into stem cell therapy for Parkinson's disease

Friday, July 24, 2009

Coverage Summary of Reprogrammed Stem Cell Breakthrough

Below is a summary of media coverage of recent experiments by Chinese researchers published in Cell Stem Cell in which a mouse was grown using reprogrammed adult stem cells:

Reuters, July 23, 2009 12:03pm EDT: "Chinese experts grow live mice from skin cells":

"Chinese researchers have managed to create powerful stem cells from mouse skin and used these to generate fertile live mouse pups. They used induced pluripotent skin cells, or iPS cells -- cells that have been reprogrammed to look and act like embryonic stem cells. Embryonic stem cells, taken from days-old embryos, have the power to morph into any cell type and, in mice, can be implanted into a mother's womb to create living mouse pups."

Time, July 23, 2009: "Mice Research Shows Promise of Adult Stem Cells":

"... two groups of scientists in China separately reported that they had created a new kind of mouse — grown entirely from a type of stem cell that originated from already mature cells, instead of from embryos. Researchers took skin cells from donor mice, reprogrammed them to revert back to an embryonic state, then programmed them again to develop into an entire mouse pup."

HealthDay News, July 23, 2009: "Scientists Use Non-Embryonic Stem Cells to Create Healthy Mice. Achievement shows how 'plastic' these cells can be, experts say":

"The mouse may be named 'Tiny,' but what it represents in the world of science is anything but that. According to Chinese researchers, the birth of Tiny (and Tiny's brethren) marks a milestone in stem cell research: Healthy, fertile animals grown using so-called pluripotent stem cells (iPS) derived not from embryonic cells, but rather cells sourced from adult mice."

Los Angeles Times, July 23, 2009: "Researchers produce cells they say are identical to embryonic stem cells":

"Two groups of Chinese researchers have performed an unprecedented feat, it was announced today, by inducing cells from connective tissue in mice to revert back to their embryonic state and producing living mice from them. By demonstrating that cells from adults can be converted into cells that, like embryonic stem cells from fetuses, have the ability to produce any type of tissue, the researchers have made a major advance toward eliminating the need for fetal cells in research and clinical applications."

Washington Post, July 24, 2009: "Researchers May Have Found Equivalent of Embryonic Stem Cells":

"Chinese scientists have bred mice from cells that might offer an alternative to human embryonic stem cells, producing the most definitive evidence yet that the technique could help sidestep many of the explosive ethical issues engulfing the controversial field but raising alarm that the advance could lead to human cloning and designer babies.

In papers published online Thursday by two scientific journals, separate teams of researchers from Beijing and Shanghai reported that they had for the first time created virtual genetic duplicates of mice using skin cells from adult animals that had been coaxed into the equivalent of embryonic stem cells."

Associated Press, July 24, 2009: "Non-embryonic stem cells pass major hurdle in mice":

"Two teams of Chinese scientists have made a major advance in mice in the development of a new kind of stem cell that doesn’t involve destroying embryos. Those cells are derived from ordinary skin cells, and when they were created two years ago from human skin and genetically reprogrammed, it was hailed as a breakthrough. But questions remained whether they could act as chameleon-like as embryonic stem cells and morph into any cell type in the body. One way to show that versatility is if the new reprogrammed stem cells could be used to produce an entire new life. And now researchers have shown they can in mice."

Cell Press, July 24, 2009: "Reprogrammed Mouse Fibroblasts Can Make A Whole Mouse":

Scientists report an important advance in the characterization of reprogrammed induced pluripotent stem cells, or iPSCs. Researchers used established methods to reprogram mouse cells to isolate five new iPSC lines, and then found that, using one of these lines, they were able to make by tetraploid complementation embryos that survived until birth, and one embryo that also survived to adulthood.

Wall Street Journal, July 24, 2009: "Chinese Scientists Reprogram Cells to Create Mice":

"Two teams of Chinese researchers working separately have reprogrammed mature skin cells of mice to an embryonic-like state and used the resulting cells to create live mouse offspring. The reprogramming may bring scientists one step closer to creating medically useful stem-cell lines for treating human disease without having to resort to controversial laboratory techniques. However, the advance poses fresh ethical challenges because the results could make it easier to create human clones and babies with specific genetic traits."

Below is a TV news segment from NBC News:

Thursday, July 23, 2009

Reprogrammed mouse fibroblasts can make a whole mouse

Source: Cell Press
Date: July 23, 2009

Summary:

In a paper publishing online July 23 in Cell Stem Cell, a Cell Press journal, Dr. Shaorong Gao and colleagues from the National Institute of Biological Sciences in Beijing, China, report an important advance in the characterization of reprogrammed induced pluripotent stem cells, or iPSCs.

Tuesday, July 21, 2009

Unraveling Flatworm Regeneration

Source: Helmholtz Association of German Research Centres
Date: July 21, 2009

Summary:

Planarian flatworms are only a few millimeters up to a few centimeters in length, live in freshwater and are the object of intense research, because they possess the extraordinary ability to regenerate lost tissue with the help of their stem cells (neoblasts) and even grow an entirely new worm out of minute amputated body parts. Now researchers from the Max Delbrück Center in Berlin, Germany together with researchers in the US and Canada present the first comprehensive catalogue of small RNAs of planaria, elements that regulate gene expression. They also have identified small RNAs which may play a role in regeneration and stem cell function, Nikolaus Rajewsky from the MDC points out in the PNAS, Early Edition.